The Immune System May Be Decreasing the Effectiveness of Gene Therapy for Duchenne Muscular Dystrophy
Since patients with Duchenne Muscular Dystrophy (DMD) lack dystrophin, reintroducing it through gene therapy may cause the immune system to mistake it for an...
During Wave, Dyne, Regenxbio, Genethon and Others Plan to File FDA Application, Potential Safety Issues in Duchenne Worry Patients
Duchenne muscular dystrophy is one of the therapy areas that has advanced the most in the last ten years. However, advancement frequently consists of...
Chilean Health Ministry Says No Clinical Evidence of Improvement for Elevidys Gene Therapy
Elevidys Gene Therapy is still being approached with skepticism by countries due to its price tag of 3 million US dollars and the lack...
Why Isn’t Roche Applying Marketing Authorization in Every Country for Elevidys Gene Therapy?
Gene therapies, particularly those like Elevidys, have the potential to revolutionize the treatment of rare and severe genetic disorders, such as Duchenne Muscular Dystrophy...
Frequently Asked Questions About Solid Biosciences SGT-003 Gene Therapy
Many research companies around the world are researching treatments for Duchenne, one of the most devastating muscle diseases. One of these is Solid Biosciences'...